Capital Markets

A market leader, Simon has advised issuers and underwriters on numerous notable capital markets transactions, including:

• IPOs by Membership Collective Group, ReNew Energy Global, Royalty Pharma, Immunocore, Vaccitech, Freeline Therapeutics, Abcam, Endava, New Energy One Acquisition Corporation, ContourGlobal, Charter Court Financial, Unicaja Banco, Wizz Air, OneSavings Bank, Royal Mail, Manchester United, Oxford Immunotec, Telepizza, Eltel, Nordax Group, Hoist Finance, Rhodes Food Group, Abengoa Yield, Thule Group, Alexander Forbes, IMCD, eDreams ODIGEO and Matas
• Equity offerings by LivaNova, Hammerson, Harmony Gold, Laboratorios Farmacéuticos Rovi, Rio Tinto, Banco Popular Espanol, Ensco, Delta Lloyd, Lar Espana Real Estate, Banco de Sabadell, Abengoa Yield, National Bank of Greece, Markit, Endesa, UBM, Alpha Bank, Ocado, Capitec Bank and Banco Espirito Santo
• Debt offerings by Novo Banco, Valeant Pharmaceuticals, IHS Markit, ArcelorMittal, Dexia Credit, Abengoa, PSG Group, Societe Generale, Worldpay Finance, Danske Bank, Credit Agricole, GE Capital, Fresnillo and IBM

Mergers and Acquisitions

Simon has significant experience advising on both public and private mergers and acquisitions transactions. Notable experience includes advising:

• Tencent on its takeover of Sumo Group
• Mereo BioPharma Group on its combination with OncoMed Pharmaceuticals
• Dai-ichi Life Holdings in connection with its investment in and strategic cooperation with Janus Capital Group and Henderson Group
• Dialog Semiconductor on its proposed $4.6 billion acquisition of Atmel
• Tesco on the sale of Fresh & Easy to Yucaipa
• Edwards Group on its sale to Atlas Copco
• MSCI on its acquisition of IPD Group
• AstraZeneca in connection with Bristol Myers Squibb’s acquisition of Amylin Pharmaceuticals